Eli Lilly and Co banner

Eli Lilly and Co
BMV:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
BMV:LLY
Watchlist
Price: 20 820.8496 MXN 0.54%
Market Cap: Mex$1T

Wall St Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 21 544.1801 MXN with a low forecast of 14 957.8547 MXN and a high forecast of 27 441.6087 MXN.

Lowest Forecast
Price Target
14 957.8547 MXN
28% Downside
Average Forecast
Price Target
21 544.1801 MXN
3% Upside
Highest Forecast
Price Target
27 441.6087 MXN
32% Upside
Eli Lilly and Co Competitors:
Price Targets
PLRX
Pliant Therapeutics Inc
150% Upside
SONO
Sonos Inc
25% Upside
LMB
Limbach Holdings Inc
71% Upside

Revenue
Forecast

8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.

Gross Profit
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 12%.

Operating Income
Forecast

15% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
15% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
13% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.

Net Income
Forecast

13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LLY's stock price target?
Price Target
21 544.1801 MXN

According to Wall Street analysts, the average 1-year price target for LLY is 21 544.1801 MXN with a low forecast of 14 957.8547 MXN and a high forecast of 27 441.6087 MXN.

What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.

What is the Gross Profit forecast for Eli Lilly and Co?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.

What is the Pre-Tax Income forecast for Eli Lilly and Co?
Projected CAGR
31%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 31%.

What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett